NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma

被引：0
|
作者：
Andrew Menzies-Gow
Gene Colice
Janet M. Griffiths
Gun Almqvist
Sandhia Ponnarambil
Primal Kaur
Gennaro Ruberto
Karin Bowen
Åsa Hellqvist
May Mo
Esther Garcia Gil
机构：
[1] Royal Brompton Hospital,Late Respiratory & Immunology
[2] BioPharmaceuticals R&D,Translational Science and Experimental Medicine, Early Respiratory & Immunology
[3] AstraZeneca,Late Respiratory & Immunology
[4] BioPharmaceuticals R&D,Late Respiratory & Immunology
[5] AstraZeneca,BioPharma Study Management, Late Respiratory & Immunology
[6] BioPharmaceuticals R&D,Biometrics, Late Respiratory & Immunology
[7] AstraZeneca,Biometrics, Late Respiratory & Immunology
[8] BioPharmaceuticals R&D,Global Medical Respiratory
[9] AstraZeneca,undefined
[10] Amgen,undefined
[11] BioPharmaceuticals R&D,undefined
[12] AstraZeneca,undefined
[13] BioPharmaceuticals R&D,undefined
[14] AstraZeneca,undefined
[15] BioPharmaceuticals R&D,undefined
[16] AstraZeneca,undefined
[17] BioPharmaceuticals Medical,undefined
[18] AstraZeneca,undefined
来源：
Respiratory Research | / 21卷
关键词：
Clinical trial; Severe asthma; Tezepelumab; Thymic stromal lymphopoietin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
    Wang, Yeming
    Zhou, Fei
    Zhang, Dingyu
    Zhao, Jianping
    Du, Ronghui
    Hu, Yi
    Cheng, Zhenshun
    Gao, Ling
    Jin, Yang
    Luo, Guangwei
    Fu, Shouzhi
    Lu, Qiaofa
    Du, Guanhua
    Wang, Ke
    Lu, Yang
    Fan, Guohui
    Zhang, Yi
    Liu, Ying
    Ruan, Shunan
    Liu, Wen
    Jaki, Thomas
    Hayden, Frederick G.
    Horby, Peter W.
    Cao, Bin
    Wang, Chen
    TRIALS, 2020, 21 (01)
  • [22] Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
    Yeming Wang
    Fei Zhou
    Dingyu Zhang
    Jianping Zhao
    Ronghui Du
    Yi Hu
    Zhenshun Cheng
    Ling Gao
    Yang Jin
    Guangwei Luo
    Shouzhi Fu
    Qiaofa Lu
    Guanhua Du
    Ke Wang
    Yang Lu
    Guohui Fan
    Yi Zhang
    Ying Liu
    Shunan Ruan
    Wen Liu
    Thomas Jaki
    Frederick G. Hayden
    Peter W. Horby
    Bin Cao
    Chen Wang
    Trials, 21
  • [23] Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial
    Heo, Sung Hyuk
    Song, Jungbin
    Kim, Bum Joon
    Kim, Hocheol
    Chang, Dae-Il
    MEDICINE, 2019, 98 (43)
  • [24] A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride
    Piessevaux, H.
    Corazziari, E.
    Rey, E.
    Simren, M.
    Wiechowska-Kozlowska, A.
    Kerstens, R.
    Cools, M.
    Barrett, K.
    Levine, A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (06) : 805 - 815
  • [25] Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial
    Zhongwei Sha
    Zhenghao Zhao
    Nana Li
    Shuyun Xiao
    Ou Li
    Jie Zhang
    Zhimin Li
    Jian Xu
    BMC Complementary Medicine and Therapies, 23
  • [26] Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial
    Sha, Zhongwei
    Zhao, Zhenghao
    Li, Nana
    Xiao, Shuyun
    Li, Ou
    Zhang, Jie
    Li, Zhimin
    Xu, Jian
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [27] A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults
    Luo, Deyan
    Pan, Hongxing
    He, Peng
    Yang, Xiaolan
    Li, Tao
    Ning, Nianzhi
    Fang, Xin
    Yu, Wenjing
    Wei, Mingwei
    Gao, Hui
    Wang, Xin
    Gu, Hongjing
    Mei, Maodong
    Li, Xinwang
    Zhang, Liangyan
    Li, Deyu
    Gao, Chunrun
    Gao, Jinbang
    Fei, Guoqiang
    Li, Ying
    Yang, Yuguo
    Xu, Yi
    Wei, Wenjin
    Sun, Yansong
    Zhu, Fengcai
    Hu, Zhongyu
    Wang, Hui
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (09):
  • [28] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
    Silberstein, Stephen D.
    Lipton, Richard B.
    Dodick, David W.
    Freitag, Frederick G.
    Ramadan, Nabih
    Mathew, Ninan
    Brandes, Jan L.
    Bigal, Marcelo
    Saper, Joel
    Ascher, Steven
    Jordan, Donna M.
    Greenberg, Steven J.
    Hulihan, Joseph
    HEADACHE, 2007, 47 (02): : 170 - 180
  • [29] Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial
    Ashrafi, Mahmoud Reza
    Salehi, Soodeh
    Malamiri, Reza Azizi
    Heidari, Morteza
    Hosseini, Seyed Ahmad
    Samiei, Mahboubeh
    Tavasoli, Ali Reza
    Togha, Mansoureh
    PEDIATRIC NEUROLOGY, 2014, 51 (04) : 503 - 508
  • [30] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
    Cuffari, Carmen
    Spalding, William
    Achenbach, Heinrich
    Thakur, Manoj
    Gabriel, Andre
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
12345